What is Ocrevus?
Ocrevus (ocrelizumab) is a monoclonal antibody used for the treatment of multiple sclerosis (MS). It is specifically approved to treat both relapsing forms of MS and primary progressive MS (PPMS). Ocrevus works by targeting CD20-positive B cells, which are believed to contribute to nerve damage in MS. By reducing these B cells, Ocrevus can help slow disease progression and reduce the frequency of relapses in MS patients.